Using advanced MRI to grade rectal cancer and predict outcomes
Part of Cancer, Digestive system clinical trials.
This trial uses a special type of MRI called IVIM-MRI to look at rectal cancer before surgery. The goal is to see if this MRI can help doctors better understand the cancer's grade and likely outcome, which could help guide treatment decisions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a special MRI scan (IVIM-MRI) of your belly and pelvis before surgery.
- You must have surgery to remove the tumor within 2 weeks of that MRI scan.
- Your doctors must have complete information about your tumor after surgery, including whether it has spread into small blood or lymph vessels.
- You cannot have had chemotherapy or radiation therapy before surgery.
- You cannot have cancer that has already spread to other parts of the body before surgery.
- Your MRI images must be clear enough for analysis, and your medical records must be complete.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses a special type of MRI scan (called amide proton transfer-weighted imaging) to look at your rectal cancer before and after chemotherapy and/or radiation. The goal is to see if the scan can predict whether the cancer has completely disappeared by the time of surgery, which could help guide future treatment decisions.
This study uses an AI computer program to read special MRI images and predict how well treatment (given before surgery) will work for people with locally advanced rectal cancer. It may help doctors better plan who benefits most from neoadjuvant therapy (treatment before surgery).
This trial uses advanced MRI scans to see how well rectal cancer is responding to radiotherapy. It may help doctors better understand which treatments work best for patients with more advanced disease.
This study looks at how an MRI “score” (mrTRG) matches how well locally advanced rectal cancer shrinks after pre-surgery chemotherapy and radiation. The goal is to use MRI results to better predict treatment response and guide care.
This study uses advanced MRI scanning and computer analysis to predict how well rectal cancer might respond to treatments given before surgery. It may help doctors choose the best approach for you.
This trial uses a special MRI before treatment to better understand early rectal cancer or suspicious large polyps. It may help doctors choose care that avoids bigger surgery when possible.
Hear when a new Rectal Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.